Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON25157Not yet recruiting
Randomised trial of vildagliptin and human insulin in ischemic stroke (4 arms), sponsored by AMC Health. Primary endpoints: Glycemic control and Hypoglycemia. Planned start Jul 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON25157.